Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Vivtex will license to Novo Nordisk select oral drug-delivery technologies and i...
Initiative positions obesity as a chronic disease and highlights role of doctor...
Darolutamide plus ADT cleared for mHSPC, supported by ARANOTE Phase III data wi...
Company secures final approval for ANDA across four strengths; cumulative USFDA...
Brecht Vanneste to take charge of MSD India operations from 1 March 2026, based...
Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustabl...
The funding coincides with the in-licensing of SLTE-1009, an anti-PACAP monoclon...
The partnership brings together a high-titre glutamine synthetase (GS) knockout ...
Event highlights intelligent automation, industry collaboration, and next-gener...
Approval covers 18 mg/3 mL prefilled pens for chronic weight management in the ...
Company initiates US launch following ANDA approval for bioequivalent to Brivia...
Value caps under the scheme have also been reduced by 50 per cent wherever appl...
Biocon Group Chairperson recognised for contributions to biomedical science and...
This marks a key development in the potential approval of adrabetadex, which cou...
These facilities will integrate advanced manufacturing technologies and AI for s...
Product is therapeutically equivalent to Jublia; company holds 234 USFDA ANDA a...
